Please ensure Javascript is enabled for purposes of website accessibility

Petersburg

100 People to Meet: Angels
Jan 21, 2021

$125M pharma manufacturing plant coming to Petersburg

Utah-based pharmaceutical manufacturer Civica Inc. plans to invest $124.5 million to establish its North American manufacturing headquarters operation in Petersburg, creating 186 jobs and manufacturing injectable medicines for the treatment of COVID-19, the governor’s office announced Thursday. A nonprofit generic drug company, Civica was established in 2018 by a group of U.S. health systems[...]

Jun 30, 2020

Cameron Foundation awards $1.13M in local grants

Petersburg-based The Cameron Foundation announced Tuesday it has awarded $1.13 million in grants to 24 nonprofit organizations in Central Virginia during its first round of funding for 2020. The two largest economic development grants went to Virginia’s Gateway Region and Virginia Local Initiatives Support Corp. (LISC). Virginia’s Gateway Region was awarded $136,063 for general operati[...]

Dr. Eric Edwards
May 19, 2020

Trump administration chooses RVA pharma startup for $354M COVID-19 contract

Richmond-based drug manufacturing company Phlow Corp., which incorporated this year, announced Tuesday that the Trump administration has awarded it a $354 million, four-year contract to manufacture in the U.S. generic medicines and pharmaceutical ingredients needed to treat COVID-19, creating an American supply chain for medical products that are now made mostly in China and India.  […]

Dec 12, 2019

Petersburg hotel operator files $28M claim in LeClairRyan bankruptcy case

Virginia hotel operator Petersburg Regency LLC filed a $28 million claim in the LeClairRyan bankruptcy case Thursday in Richmond, according to the federal court filing. Petersburg Regency is seeking relief from an automatic stay in LeClairRyan’s handling of an insurance dispute from 2003’s Hurricane Isabel. An automatic stay ensures equality of distribution by preventing one […]

YOUR NEWS.
YOUR INBOX.
DAILY.

By subscribing you agree to our Privacy Policy.